throbber
Original Paper
`
` ORL 2012;74:149–153
` DOI: 10.1159/000337830
`
` Received: December 20, 2011
` Accepted after revision: February 22, 2012
` Published online: April 13, 2012
`
` Effects of Benzalkonium Chloride and
`Potassium Sorbate on Airway Ciliary
`Activity
`
` Chengshuo Wang a Qiu Deng b Demin Han a, b Luo Zhang a, b
`
` a Department of Otolaryngology, Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University,
`and b Key Laboratory of Otolaryngology, Head and Neck Surgery (Ministry of Education), Beijing Institute of
`Otolaryngology, Beijing , China
`
` Key Words
` Preservatives ⴢ Ciliary beat frequency ⴢ Benzalkonium
`chloride ⴢ Potassium sorbate
`
`CBF after 10 min of exposure, respectively. Conclusions: PS
`could be considered as a safer and more promising preserva-
`tive than BKC for use in topical formulations.
` Copyright © 2012 S. Karger AG, Basel
`
` Abstract
` Objectives: Preservatives are indispensable components of
`aqueous multidose topical formulations. The purpose of our
`study was to investigate the effects of two representative
`preservatives, benzalkonium chloride (BKC) and potassium
`sorbate (PS), on rabbit tracheal ciliary beat frequency (CBF).
` Methods: Rabbit tracheal ciliated cell culture was estab-
`lished and CBF was determined using high-speed digital im-
`aging methods. The effects of preservatives at different con-
`centrations on CBF were observed over a 10-min exposure
`period. Results: BKC induced inhibition of CBF in a concen-
`tration-dependent manner. Ciliary beating was stopped by
`0.01% BKC after 5 min of exposure. A low concentration of PS
`(0.12%) only resulted in a mild decrease in CBF during a 10-
`min exposure. The CBF decreased by 13.0% from baseline
`after 10 min. However, there was no statistically significant
`difference compared with the corresponding control condi-
`tion. Application of 0.24, 0.48 and 0.96% of PS to rabbit tra-
`cheal cells resulted in an increase in CBF, with an increase of
`105 8 9.8, 107.6 8 4.0, and 117.1 8 9.5% relative to baseline
`
` Introduction
`
` The administration of drugs via the upper airway (na-
`sal) or lower airway (tracheal and bronchial) has become
`a common method of medication in recent years. In par-
`ticular, nasal sprays or drops have been widely used for
`respiratory tract disorders of the nasal cavity and para-
`nasal sinuses in the field of otorhinolaryngology. A pre-
`requisite of nasally applied preparations is that drugs and
`additives in the dosage form do not interfere with normal
`nasal functioning, such as the nasal mucociliary clear-
`ance system [1] . Mucociliary clearance is one of the most
`important local defense mechanisms of the respiratory
`tract. The coordinated beating of cilia plays an essential
`role in efficient mucociliary clearance, and ciliary beat
`frequency (CBF) is one of the basic functional ciliary pa-
`
` D.H. and L.Z. contributed equally to the study.
`
`Fax +41 61 306 12 34
`E-Mail karger@karger.ch
`www.karger.com
`
` © 2012 S. Karger AG, Basel
`0301–1569/12/0743–0149$38.00/0
`
` Accessible online at:
`www.karger.com/orl
`
` Luo Zhang, MD
` Beijing Institute of Otolaryngology
` No. 17, Hou Gou Hu Tong, Dong Cheng District
` Beijing, 100005 (China)
` Tel. +86 10 6514 1136, E-Mail dr.luozhang   @   gmail.com
`
`Opiant Exhibit 2095
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00688
`Page 1
`
`

`

`rameters [2] . Hence, it is important to investigate the in-
`fluence of active drugs and additives in the dosage form
`on CBF to evaluate the safety of nasally administered
`drugs and various additives such as preservatives [1] .
` Preservatives are indispensable components of tradi-
`tional multidose nasal formulations due to the necessity
`for repeated administration and their aqueous nature,
`which is susceptible to microorganism infestation. Ben-
`zalkonium chloride (BKC) is a quaternary ammonium
`compound, which is by far the most commonly used pre-
`servative for the prevention of bacterial contamination in
`nasal sprays or drops. Although it has been recognized
`that excipients in nasal formulations should be harmless
`to nasal tissues, several studies have demonstrated the im-
`pairment of mucociliary clearance by BKC [3–5] . Potassi-
`um sorbate (PS) is a white crystalline powder which is used
`in foods, cosmetics and drug preparations to inhibit mold,
`yeast and bacterial growth. Recent research data suggest
`that PS may be a safer preservative for nasal ciliated epi-
`thelium [6, 7] . The purpose of the present study was to
`determine the effects of BKC and PS on CBF in rabbit tra-
`cheal mucosa cultures and to compare their ciliotoxicities.
`
` Materials and Methods
`
` Chemicals and Materials
` Dulbecco’s modified Eagle medium (DMEM) and sterile
`Hanks’ balanced salt solution (sHBSS) were purchased from Sig-
`ma Co. Ltd. 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid
`and flavin mononucleotide were purchased from Merck. Strepto-
`mycin sulfate was purchased from Amresco, penicillin G sodium
`salt and amphotericin B solubilized from Sigma. BKC and PS were
`purchased from Sigma.
`
` Tissue Isolation and Culture
` The establishment of rabbit tracheal epithelium primary cul-
`tures has been described in detail previously [8] . Briefly, tracheas
`were removed aseptically from 2-month-old New Zealand rab-
`bits. The tracheal epithelium was separated from the underlying
`cartilage and cut into 1-mm 2 explants. As needed, explants were
`placed onto slides precoated with a thin film of rat tail collagen,
`which were placed into four-well dishes in advance (one or two
`explants per slide). Petri dishes were then added to a minimal
`amount of DMEM/NaHCO 3 culture medium supplemented with
`10% fetal calf serum and antibiotics (penicillin, 100 U/ml; strep-
`tomycin, 100 U/ml, and amphotericin B, 0.25 ␮ g/ml). After a few
`minutes, explant adherence had occurred and 0.5 ml culture me-
`dium was added to each culture dish. Cultures were incubated in
`humidified 95% air/5% CO 2 at 37   °   C, and the culture medium was
`changed every 2 days.
`
` Measurement of CBF
` Six- to eight-day tissue cultures were used for measurements
`of CBF. Fields of view with well-grown rabbit tracheal cilia which
`
`swung regularly were selected using an inverted microscope
`(Olympus IX 71, Tokyo, Japan) at a magnification of ! 400. The
`images of cilia were captured by a high-speed digital camera cap-
`ture system (PULNiX High-Speed Digital) at a frame rate of 240
`frames per second with a sampling interval of 3 s and results were
`transmitted to a computer workstation. A region of interest was
`selected and analyzed with IPLab4.0 software. CBF was calcu-
`lated by determination of fluctuations in light intensity [8, 9] . All
`experiments were performed at a constant temperature of 25 8
`1   °   C.
` The effect of preservatives on CBF was determined over a 10-
`min period of exposure. The four-well culture plates were re-
`moved from the incubator at least 1 h before the start of the ex-
`periment in order to allow the medium to adapt to ambient tem-
`perature. The cell culture medium was replaced by 1 ml of sHBSS
`and the culture left to stabilize for at least 10 min, after which CBF
`was recorded as baseline values of CBF (prior to exposure). The
`sHBSS was then replaced by 1 ml of a solution of the preservative
`to be tested and CBF was determined at 1, 2, 3, 4, 5, 6, 7, 8, 9 and
`10 min after exposure. The test concentrations were 0.005, 0.0075
`and 0.01% for BKC and 0.12, 0.24, 0.48 and 0.96% for PS. All con-
`centrations of preservatives were prepared in sHBSS (pH 7.4).
`
` Data Presentation and Statistical Analysis
` All data were expressed as percentages relative to the baseline
`values, which were considered as 100% and presented as mean
`percentage 8 SD. The differences of data between and within
`groups were statistically analyzed by analysis of variance followed
`by Student’s t test using Microsoft Excel 2002. A p value ! 0.05 was
`considered as significant.
`
` Results
`
` Effect of BKC on CBF
` Figure 1 shows the effects of BKC (0.0, 0.005, 0.0075
`and 0.01%) on the CBF of rabbit tracheal cilia. The abso-
`lute value of CBF in test conditions ranged from ⬃ 8 to
` ⬃ 14 Hz and the value of controls remained constant over
`the 10 min of the experiments. The CBF was significantly
`increased by up to 42.2% at 3 min after exposure to 0.005%
`BKC, which was statistically significant compared with
`the corresponding control condition (p ! 0.01). However,
`CBF gradually decreased and the difference between
`0.005% BKC and the control group was reduced to 13.4%
`at 10 min after exposure (p ! 0.05). At a concentration of
`0.0075% BKC, CBF dramatically decreased over time.
`Mean CBF decreased by up to 90.3% of the baseline level
`after 10 min of exposure, in which 76.9% of cilia were ob-
`served to be in stasis. At a concentration of 0.01% BKC,
`there were 2 out of 13 ciliated cells (15.4%) in ciliostasis
`after a 3-min exposure period, and all ciliary beat activity
`had completely ceased at 6 min after exposure. Overall,
`BKC demonstrated significant concentration-dependent
`inhibitory effects on CBF ( table 1 ).
`
`150
`
`ORL 2012;74:149–153
`
` Wang   /Deng   /Han   /Zhang
`
`Opiant Exhibit 2095
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00688
`Page 2
`
`

`

`0
`
`1
`
`2
`
`3
`
`0.00% (n = 14)
`0.12% (n = 10)
`0.24% (n = 11)
`
`4
`
`5
`Time (min)
`
`6
`
`0.48% (n = 10)
`0.96% (n = 14)
`
`7
`
`8
`
`9
`
`10
`
`140
`
`120
`
`100
`
`80
`
`60
`
`40
`
`20
`
`CBF (% baseline)
`
`sHBSS
`0.005% BKC
`
`0.0075% BKC
`0.01% BKC
`
`200.0
`
`150.0
`
`100.0
`
`50.0
`
`CBF (% baseline)
`
`0
`
`0
`
`1
`
`2
`
`3
`
`4
`
`6
`5
`Time (min)
`
`7
`
`8
`
`9
`
`10
`
` Fig. 1. Effect of BKC at different concentrations on the CBF of rab-
`bit tracheal cilia. CBF values were calculated as percentages of
`CBF values at baseline (immediately before exposure). The expo-
`sure period was 10 min. BKC showed strongly concentration-de-
`pendent inhibitory effects on the CBF. In the 0.01% group, muco-
`ciliary activities were completely inhibited by 0.01% BKC by 5 min
`after exposure.
`
` Fig. 2. Effect of PS at different concentrations on the CBF of rabbit
`tracheal cilia. CBF values were calculated as percentages of CBF
`values at baseline (immediately before exposure). The exposure
`period was 10 min. A trend of increase in CBF as a function of
`concentration was observed. There were significant differences
`compared with the corresponding control condition at 10 min
`after exposure at concentrations of 0.24, 0.48 and 0.96% (p ! 0.01).
`
`Table 1. Changes in CBF measurements for BKC at different concentrations tested over 10 min in rabbit trachea in vitro
`
`Concentration
`
`C BF, %
`
`0 min
`
`1 min
`
`2 min
`
`3 min
`
`4 min
`
`5 min
`
`6 min
`
`7 min
`
`8 min
`
`9 min
`
`10 min
`
`100810.2 110.9815.8 98.1813.9 96.9811.4 95.3812.1 95.6812.6 95.086.8
`
`94.686.6
`
`sHBSS (n = 14)
`BKC
`0.005% (n = 13) 100810.5 131.5816.0 136.6818.3 137.5818.0*137.2818.9*133.5820.9 129.5823.9 123.7828.3 116.5832.2 111.8835.0 105.8836.1
`0.0075% (n = 13) 10089.3
`139.8816.9 112.9835.9 79.2844.0 54.3839.3 42.6839.3 34.3834.6 24.7830.1 18.9826.3 11.4821.9
`9.3817.9
`10088.7
`90.6832.1 51.5830.4 23.5830.5
`7.4818.3
`0.080.0
`0.01% (n = 12)
`–
`–
`–
`–
`–
`
`95.187.3
`
`92.987.4
`
`91.686.8
`
`Al l data are expressed as percentages relative to baseline values (immediately before exposure, i.e. 0 min) which were considered as 100% and are presented
`as mean percentage 8 SD. * p < 0.01, compared with the sHBSS group (control).
`
`Table 2. Changes in CBF measurements for PS at different concentrations tested over 10 min in rabbit trachea in vitro
`
`Concentration
`
`C BF, %
`
`sHBSS (n = 14)
`PS
`0.12% (n = 10)
`0.24% (n = 11)
`0.48% (n = 10)
`0.96% (n = 14)
`
`0 min
`
`1 min
`
`2 min
`
`3 min
`
`4 min
`
`5 min
`
`6 min
`
`7 min
`
`8 min
`
`9 min
`
`10 min
`
`100810.2 110.9815.8
`
`98.1813.9
`
`96.9811.4
`
`95.3812.1
`
`95.6812.6
`
`95.086.8
`
`94.686.6
`
`95.187.3
`
`92.987.4
`
`91.686.8
`
`10089.5
`10087.6
`10087.5
`10088.3
`
`85.5811.9
`87.5810.9
`89.888.1
`90.2819.9
`96.3817.2
`88.1815.1
`100.3813.7 100.3815.5 103.9811.3 104.9811.3 104.7811.1 103.3814.5
`113.486.4
`108.783.4
`110.285.9
`106.988.0
`108.686.6
`107.286.6
`122.188.2
`117.187.6
`117.387.6
`117.587.9
`117.288.6
`117.088.9
`
`83.6815.7
`10589.1
`107.085.7
`116.589.0
`
`86.5810.8
`106.389.8
`106.486.2
`116.589.6
`
`87.0811.1
`83.6812.4
`104.7811.2 105.589.8*
`106.985.1
`107.684.0*
`116.689.6
`117.189.5*
`
`All data are expressed as percentages relative to baseline values (immediately before exposure, i.e. 0 min) which were considered as 100% and are presented
`as mean percentage 8 SD. * p < 0.01, compared with the sHBSS group (control).
`
` Effects of Preservatives on Rabbit
`Tracheal Ciliary Movement
`
`ORL 2012;74:149–153
`
`151
`
`Opiant Exhibit 2095
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00688
`Page 3
`
`

`

`well as the difference between in vitro and in vivo condi-
`tions [13, 14] . Particularly, there was a lack of a mucus
`layer in vitro, which protects the ciliated epithelium of the
`nasal cavity. It is worth noting that most results showing
`no deleterious effects on CBF were observed in in vivo
`studies. Given the healthy human nose has about 0.4 ml
`mucus [15] and generally spray dose volumes are of the
`order of 0.1 ml in clinical practice, a fivefold dilution of
`nasal preparations may, in fact, be more realistic when
`considering ciliotoxic potential. Thus, in establishing the
`actual toxicity of preservatives, measuring CBF in vitro
`is probably too sensitive an approach. In our study, CBF
`demonstrated extreme sensitivity to changes in the con-
`centration of BKC, as shown by changes from a strong
`inhibition of mucociliary activity by 0.01% BKC to a slight
`and positive stimulation by 0.005%, which was only half
`the original level. Given that the most commonly used
`concentration of BKC as a preservative in clinical practice
`is 0.01%, the actual concentration of BKC in the nasal cav-
`ity after administration of nasal drops or sprays is ex-
`pected to be below 0.005% due to dilution. This could
`therefore explain the fact that the deleterious effects on
`nasal ciliated epithelium in vitro are not reflected in the
`findings in vivo or in the clinic.
` On the other hand, PS concentrations in the range of
`0.12–0.96% showed no significant effects on CBF in this
`study. As discussed above, although in vitro experiments
`could not precisely duplicate in vivo conditions due to the
`lack of a protective mucus layer, in vitro experiments on
`CBF are a very useful tool for studying the ciliotoxicity of
`various compounds due to their controllable properties
`without other interfering factors such as stress, hormone
`secretion or inflammatory mediators. If there is an effect
`on CBF observed in vitro under standardized conditions
`and the exclusion of cofactors, it can be assumed that
`such an effect does exist in vivo. As our study shows, PS
`was a safer preservative than BKC on CBF at the com-
`monly used concentrations (0.01% for BKC and 0.12% for
`PS, fig. 3 ). There was only a mild increase in CBF even
`when the concentration of PS tested was up to 0.96%
`(about 5 times the commonly used concentration).
` In conclusion, the potential ciliotoxicity of BKC at the
`concentration commonly used in nasal formulations
`(0.01%) was proven. However, a slight, positive effect on
`CBF was observed for BKC when the concentration was
`diluted to half of the original value, i.e. 0.005%, implying
`that BKC may be a cilia-friendly preservative in the hu-
`man nasal cavity. By contrast, PS showed no effect on
`mucociliary activity and is thus considered as a safer and
`more promising preservative.
`
`sHBSS (n = 14)
`0.12% PS (n = 10)
`0.01% BKC (n = 12)
`
`140
`
`120
`
`100
`
`80
`
`60
`
`40
`
`20
`
`CBF (% baseline)
`
`0
`
`0
`
`2
`
`4
`Time (min)
`
`6
`
`8
`
`10
`
` Fig. 3. Comparison of effects of BKC and PS at the concentration
`used in nasal formulations (0.01 and 0.12%, respectively) on CBF.
`As shown in the graph, mucociliary activities were completely
`inhibited by 0.01% BKC at 5 min, while there was no notable effect
`of PS at 0.12% during 10 min of exposure compared with the cor-
`responding control condition.
`
` Effect of PS on CBF
` Generally, there was no notable effect of PS on CBF. As
`shown in figure 2 , a trend of CBF increase with PS con-
`centration increase from 0.12 to 0.96% was observed. A
`low concentration of PS (0.12%) only resulted in a mild
`decrease in CBF during the 10 min of exposure. The CBF
`decreased by 13.0% from baseline after 10 min, although
`this was not statistically significant compared with the
`corresponding control condition. Application of 0.24,
`0.48 and 0.96% PS to rabbit tracheal cilia cells resulted in
`an increase in CBF, with increases of 105 8 9.8, 107.6 8
`4.0, and 117.1 8 9.5% relative to baseline CBF after 10
`min of exposure, respectively (all p ! 0.01 compared with
`the corresponding control condition, table 2 ).
`
` Discussion
`
` BKC is a preservative widely used in topical multidose
`formulations to prevent contamination. Its effect on nasal
`mucociliary clearance has not been clearly established.
`Some studies, including both in vitro and in vivo studies
` [3–5] , have suggested that BKC does produce adverse ef-
`fects on mucociliary activity. Other data, however, sug-
`gest BKC lacks deleterious effects [10–13] . The discrep-
`ancy in these results, particularly between in vitro and in
`vivo findings, could be explained by the possibility of
`problems in the experimental design and methodology as
`
`152
`
`ORL 2012;74:149–153
`
` Wang   /Deng   /Han   /Zhang
`
`Opiant Exhibit 2095
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00688
`Page 4
`
`

`

` Acknowledgments
`
` Disclosure Statement
`
` This work was supported by grants from the National Science
`Fund for Distinguished Young Scholars (81025007), National
`Natural Science Foundation of China (30973282), Beijing Natural
`Science Foundation (7102030) and the Special Fund of Sanitation
`Elite Reconstruction of Beijing (2009-2-007) to L.Z.
`
` The authors declare that they have no conflict of interest.
`
` References
`
` 1 Merkus P, Romeijn SG, Verhoef JC, et al:
`Classification of cilio-inhibiting effects of
`nasal drugs. Laryngoscope 2001; 111: 595–
`602.
` 2 Jorissen M, Willems T, De Boeck K: Diag-
`nostic evaluation of mucociliary transport:
`from symptoms to coordinated ciliary activ-
`ity after ciliogenesis in culture. Am J Rhinol
`2000; 14: 345–352.
`3 Graf P, Hallen H: Effect on the nasal mucosa
`of long-term treatment with oxymetazoline,
`benzalkonium chloride, and placebo nasal
`sprays. Laryngoscope 1996; 106: 605–609.
`4 Riechelmann H, Deutschle T, Stuhlmiller A,
`et al: Nasal toxicity of benzalkonium chlo-
`ride. Am J Rhinol 2004; 18: 291–299.
`5 Mallants R, Jorissen M, Augustijns P: Effect
`of preservatives on ciliary beat frequency in
`human nasal epithelial cell culture: single
`versus multiple exposure. Int J Pharm 2007;
` 338: 64–69.
` 6 Hofmann T, Gugatschga M, Koidl B, et al:
`Influence of preservatives and topical ste-
`roids on ciliary beat frequency in vitro. Arch
`Otolaryngol Head Neck Surg 2004; 130: 440–
`445.
`
` 7 Ho CY, Wu MC, Lan MY, et al: In vitro ef-
`fects of preservatives in nasal sprays on hu-
`man nasal epithelial cells. Am J Rhinol 2008;
` 22: 125–129.
`8 Zhang L, Sanderson MJ: Oscillations in cili-
`ary beat frequency and intracellular calcium
`concentration in rabbit tracheal epithelial
`cells induced by ATP. J Physiol 2003; 546:
` 733–749.
`9 Zhang L, Han D, Sanderson MJ: Effect of iso-
`proterenol on the regulation of rabbit airway
`ciliary beat frequency measured with high-
`speed digital and fluorescence microscopy.
`Ann Otol Rhinol Laryngol 2005; 114: 399–
`403.
` 10 McMahon C, Darby Y, Ryan R, et al: Imme-
`diate and short-term effects of benzalkoni-
`um chloride on the human nasal mucosa in
`vivo. Clin Otolaryngol Allied Sci 1997; 22:
` 318–322.
`
` 11 Boek WM, Graamans K, Natzijl H, et al: Na-
`sal mucociliary transport: new evidence for
`a key role of ciliary beat frequency. Laryngo-
`scope 2002; 112: 570–573.
` 12 Braat JP, Ainge G, Bowles JA, et al: The lack
`of effect of benzalkonium chloride on the
`cilia of the nasal mucosa in patients with pe-
`rennial allergic rhinitis: a combined func-
`tional, light, scanning and transmission
`electron microscopy study. Clin Exp Allergy
`1995; 25: 957–965.
` 13 Berg OH, Lie K, Steinsvåg SK: The effects of
`topical nasal steroids on rat respiratory mu-
`cosa in vivo, with special reference to benzal-
`konium chloride. Allergy 1997; 52: 627–632.
` 14 Marple B, Roland P, Benninger M: Safety re-
`view of benzalkonium chloride used as a pre-
`servative in intranasal solutions: an over-
`view of conflicting data and opinions. Oto-
`laryngol Head Neck Surg 2004; 130: 131–141.
` 15 Stanley PJ, Wilson R, Greenstone MA, et al:
`Abnormal nasal mucociliary clearance in
`patients with rhinitis and its relationship to
`concomitant chest disease. Br J Dis Chest
`1985; 79: 77–82.
`
` Effects of Preservatives on Rabbit
`Tracheal Ciliary Movement
`
`ORL 2012;74:149–153
`
`153
`
`Opiant Exhibit 2095
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00688
`Page 5
`
`

`

`Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
`
`Opiant Exhibit 2095
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00688
`Page 6
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket